BioScrip to Present at BMO Capital Markets 9th Annual Focus on Healthcare Conference.ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS BIOS in full Basic Input/Output System Computer program that is typically stored in EPROM and used by the CPU to perform start-up procedures when the computer is turned on. ) today announced that it will present at the BMO BMO Bank of Montreal (Canada) BMO Before Market Open BMO Biometrics Management Office BMO Ballistic Missile Office BMO British Mathematical Olympiad BMO Balkan Mathematical Olympiad BMO Business Management Office Capital Markets 9th Annual Focus on Healthcare Conference on Wednesday, August 5,2009 at the Millennium Broadway Hotel in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . BioScrip's Chairman and Chief Executive Officer, Richard H. Friedman, and Stanley G. Rosenbaum, Executive Vice President and Chief Financial Officer will present at 9:30 AM ET (Eastern Time). Investors may access a live audio web cast of BioScrip's presentation at the following link: http://www.bmocm.com/conferences/2009healthcare/webcast/. A web cast replay of the presentation can also be accessed via BioScrip's website at www.bioscrip.com, under the Investors section. About BioScrip, Inc. BioScrip, Inc. is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payors and pharmaceutical manufacturers to provide access to medications and management solutions to optimize optimize - optimisation outcomes for chronic and other complex health care conditions. Forward Looking Statements-Safe Harbor This press release may contain statements which constitute forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company, Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion